Home

Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH
Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation
Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Compliance Manager
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Acoustic Mass Spectrometry
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community

Resources

JALA Special Issue
Publications
Articles and Other Media
Application Notes
Posters
Webinars
Videos
Customer Profiles
Core Labs

Support

Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Meet Labcyte
Careers
Contact and Location
Privacy Policy

Labcyte BLOG

At SynBioBeta London, a Maturing Field Garners Industrial Interest
THURSDAY, APRIL 21, 2016
linkedin twitter facebook |  44Shares

The Labcyte team was delighted to participate in the recent SynBioBeta meeting held in London. It’s the second year we’ve exhibited at this great event, and it was gratifying to find that even more people there have been using our tools to propel their synthetic biology projects forward.


At this meeting, we noticed more interest in synthetic biology from industrial companies and the investment community — a strong indicator that this field is maturing beyond the academic research lab. There was a tangible sense among attendees that synthetic biology is starting to realize its potential in applications that are truly making a difference in the world, such as pharmaceutical production or environmentally sustainable chemical development. As more and more scientists use the design-build-test approach to create everything from biofuels to cosmetics, it’s clear that synbio-based manufacturing — often using engineered bacteria as miniature factories — is becoming a reality.


One of the advances underlying the growth of synthetic biology has been new technology that makes it possible to assemble and validate synthetic DNA at massive scale with very low costs. Labcyte’s contribution to the field is our Echo platform, a tipless acoustic liquid handling tool that operates at nanoliter scale and drastically reduces reagent use.


Scientists use the Echo platform to perform high-throughput cherry-picking of oligo libraries to create DNA fragments using one-pot assembly techniques, such as Gibson or GoldenGate Assembly. The Echo instrument allows customers to ensure reliable, accurate operation without the risk of cross-contamination that occurs with systems using plastic tips.


Further along in the process, the Echo platform is used again for characterization of the DNA fragments, which can be done with qPCR, NGS, or other techniques. Customers tell us that the system’s ease of use and efficiency make Echo a go-to platform in the synbio experimental pipeline.


We look forward to seeing continued development in this field, and we congratulate the Echo users who presented great results at SynBioBeta London!